stars 1 stars 2 stars 3

Kanaph Therapeutics is a drug discovery and pre-clinical stage biotech based in Korea, with a large and small molecule two-track strategy for the development of first-in-class and best-in-class therapeutics in immuno-oncology, targeted therapy and autoimmune (ophthalmology) diseases. Our oncology pipeline includes bi-specific antibodies and small molecules that have a greatly enhanced immuno-stimulatory activity in the tumor micro-environment (TME) for efficient tumor eradication. Our autoimmune disease pipeline is composed of bispecific Fc-fusions that inhibit the alternative complement pathway while inhibiting angiogenesis and downstream complement activation as well.

View Top Employees from Kanaph Therapeutics
Employees 15 (9 on RocketReach)
Founded 2019
JavaScript, HTML, PHP +5 more (view full list)
Category Pharmaceutical Manufacturing, Drug Discovery, Biotechnology

Kanaph Therapeutics Questions

Youngsook Shin is the Executive Vice President of Kanaph Therapeutics.

9 people are employed at Kanaph Therapeutics.

Top Kanaph Therapeutics Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
G2Crowd Trusted
300K+ Plugin Users